Literature DB >> 12846773

Differences in bone turnover and intact PTH levels between African American and Caucasian patients with end-stage renal disease.

B Peter Sawaya1, Rezkalla Butros, Shehzab Naqvi, Zhaopo Geng, Hanna Mawad, Robert Friedler, Paolo Fanti, Marie-Claude Monier-Faugere, Hartmut H Malluche.   

Abstract

BACKGROUND: Evidence derived from healthy subjects suggests that African Americans have higher serum parathyroid hormone (PTH) levels and decreased bone responsiveness to PTH than Caucasians. African American patients with end-stage renal disease (ESRD) also have higher serum PTH than Caucasians. Studies that correlate intact PTH (iPTH) levels with bone turnover in ESRD patients were performed in a predominantly Caucasian population.
METHODS: In this study, serum iPTH and bone histomorphometric data were analyzed for racial differences in 76 ESRD patients (Caucasian = 48, African Americans = 28). Bone turnover was determined by histomorphometric measurement of activation frequency in all patients.
RESULTS: Age, duration of dialysis, and calcium and phosphorus levels were similar between the two groups. iPTH levels (pg/mL; mean +/- SE) were significantly higher in the African American group (534 +/- 79 vs. 270 +/- 46, P < 0.01). Also, alkaline phosphatase levels (IU/L) were significantly higher in the African American group (162 +/- 31 vs. 144 +/- 43, P < 0.01). Correlations between PTH levels and activation frequency were r = 0.60, P < 0.01 in Caucasians and r = 0.22, P = NS in African Americans. The mean PTH level in African American patients with histologic findings of low bone turnover was 460 +/- 115 vs. 168 +/- 41 in Caucasian patients with similar bone turnover (P < 0.01). In patients with low bone turnover, African Americans had significantly higher osteoid volume and thickness, number of osteoblasts and osteoclasts, erosion surface, peritrabecular fibrosis, and single-label surface than Caucasians. However, erosion depth, bone formation rate per osteoblast and mineralization apposition rate were similar between the two groups.
CONCLUSION: There is no correlation between iPTH and bone turnover in African Americans with ESRD. A substantial number of African American patients with low bone turnover have very high serum PTH levels. Bone histomorphometric results reveal differences in remodeling dynamics and responses to PTH between African American and Caucasian patients. Further studies utilizing newer PTH measurement assays are needed to better delineate the correlation between PTH and bone turnover in the various racial groups.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12846773     DOI: 10.1046/j.1523-1755.2003.00129.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  24 in total

1.  Calcium-Sensing Receptor Genotype and Response to Cinacalcet in Patients Undergoing Hemodialysis.

Authors:  Sharon M Moe; Leah Wetherill; Brian Scott Decker; Dongbing Lai; Safa Abdalla; Jin Long; Matteo Vatta; Tatiana M Foroud; Glenn M Chertow
Journal:  Clin J Am Soc Nephrol       Date:  2017-06-19       Impact factor: 8.237

2.  Intact PTH combined with the PTH ratio for diagnosis of bone turnover in dialysis patients: a diagnostic test study.

Authors:  Johann Herberth; Adam J Branscum; Hanna Mawad; Tom Cantor; Marie-Claude Monier-Faugere; Hartmut H Malluche
Journal:  Am J Kidney Dis       Date:  2010-03-27       Impact factor: 8.860

3.  Can the combination of calcium and parathormone levels above K/DOQI guidelines be used as a marker of adynamic bone disease in African Americans?

Authors:  Charles J Diskin; Thomas J Stokes; Linda M Dansby; Lautrec Radcliff; Thomas B Carter
Journal:  Int Urol Nephrol       Date:  2010-06-12       Impact factor: 2.370

4.  Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response.

Authors:  Steven J Weintraub; Jacquelyn F Fleckenstein; Tony N Marion; Margaret A Madey; Tahar M Mahmoudi; Kenneth B Schechtman
Journal:  Am J Clin Nutr       Date:  2012-09-26       Impact factor: 7.045

5.  The link between bone and coronary calcifications in CKD-5 patients on haemodialysis.

Authors:  Gulay Asci; Ercan Ok; Recep Savas; Mehmet Ozkahya; Soner Duman; Huseyin Toz; Meral Kayikcioglu; Adam J Branscum; Marie-Claude Monier-Faugere; Johann Herberth; Hartmut H Malluche
Journal:  Nephrol Dial Transplant       Date:  2010-08-13       Impact factor: 5.992

6.  The new kidney disease: improving global outcomes (KDIGO) guidelines - expert clinical focus on bone and vascular calcification.

Authors:  G London; D Coyne; K Hruska; H H Malluche; K J Martin
Journal:  Clin Nephrol       Date:  2010-12       Impact factor: 0.975

7.  Screening for chronic kidney disease complications in US adults: racial implications of a single GFR threshold.

Authors:  Hassan N Ibrahim; Changchun Wang; Areef Ishani; Allan J Collins; Robert N Foley
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-10       Impact factor: 8.237

8.  Ethnicity, socioeconomic status, and attainment of clinical practice guideline standards in dialysis patients in the United kingdom.

Authors:  Udaya P Udayaraj; Yoav Ben-Shlomo; Paul Roderick; Retha Steenkamp; David Ansell; Charles R V Tomson; Fergus J Caskey
Journal:  Clin J Am Soc Nephrol       Date:  2009-04-08       Impact factor: 8.237

9.  Relationship between bone histology and markers of bone and mineral metabolism in African-American hemodialysis patients.

Authors:  Carol Moore; Jerry Yee; Hartmut Malluche; D Sudhaker Rao; Marie-Claude Monier-Faugere; Elizabeth Adams; Olufunmilola Daramola-Ogunwuyi; Hassan Fehmi; Saroj Bhat; Yahya Osman-Malik
Journal:  Clin J Am Soc Nephrol       Date:  2009-09       Impact factor: 8.237

10.  Bone Parameters and Risk of Hip and Femur Fractures in Patients on Hemodialysis.

Authors:  Steven Fishbane; Azzour D Hazzan; Kenar D Jhaveri; Lin Ma; Eduardo Lacson
Journal:  Clin J Am Soc Nephrol       Date:  2016-03-29       Impact factor: 8.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.